Reimbursement Support
Community Access Patient Program (CAPP)
At EUSA Pharma, we understand that obtaining the medicine you need can be complicated by healthcare reimbursement. To make this process easier, we created CAPP. The CAPP provides complimentary reimbursement services to help answer questions related to insurance coverage and reimbursement. CAPP also directs patients to our assistance program, which can provide Erwinaze free of charge to eligible patients.
Use the navigation buttons above to learn about the available support programs. For any questions about obtaining Erwinaze reimbursement assistance, please contact:
AccessMED
6900 College Boulevard #1000
Overland Park, KS 66211
Phone: 888-837-4397
Fax: 866-287-3036
E-mail: EUSAPharma@accessmed.com
Customer Service Hours: Monday - Friday 8:00 am - 5:00 pm CST
Selected Risk Information about Erwinaze™ (asparaginase Erwinia chrysanthemi)
CONTRAINDICATIONS: Hx of serious hypersensitivity to Erwinaze, including anaphylaxis; Hx of serious pancreatitis, thrombosis or hemorrhage with prior L-asparaginase therapy.
WARNINGS AND PRECAUTIONS: Discontinue if serious hypersensitivity, including anaphylaxis, OR severe or hemorrhagic pancreatitis occur. Monitor glucose (intolerance may not be reversible); With thrombosis and hemorrhage: discontinue until resolved. Use in pregnant women only if clearly needed. Do not use in lactating women.
COMMON (≥ 1%) ADVERSE REACTIONS: Serious hypersensitivity, including anaphylaxis, pancreatitis, abnormal transaminases, coagulation abnormalities, nausea, vomiting, and hyperglycemia.
Please see full Prescribing Information.
This site is only intended for residents of the United States.